At first glance, the takeover of Daiichi Sankyo Healthcare by Suntory Holdings earlier this month appears to be of only passing interest to the global drinks trade. A little curiosity might be piqued by the magnitude of the deal – Y246.5bn or around $1.6bn – but what does the acquisition of an over-the-counter pharmaceuticals concern have to do with the world of booze?